
NMD Pharma Initiates Phase 2b Trial of NMD670 in Generalized Myasthenia Gravis Patients 11 June 2024
Aarhus, Denmark, 11 June 2024 – NMD Pharma A/S, a clinical-stage biotech company dedicated to developing... Read more

Aarhus, Denmark, 11 June 2024 – NMD Pharma A/S, a clinical-stage biotech company dedicated to developing... Read more

Lophora, a clinical-stage CNS drug discovery company developing novel, next generation 5HT2ARA medicines... Read more

Oslo, Norway, May 14, 2024 – Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical... Read more

Scandion Oncology (Scandion), a biotech company developing first-in-class medicines aimed at treating... Read more

May 13, 2024 (COPENHAGEN, Denmark). Zerion Pharma A/S (“ZERION”) today announces positive results... Read more
We are happy to tell you that we have entered cooperation with BioFIT and MedFIT for the 2024 conference... Read more

Boston (May 2, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR),... Read more

As Dansk Biotek has been a supporter for NLSDays 2024 in Malmö, I’m happily sharing with you that... Read more

Participate now in The Danish Biotech Salary Survey 2024 to find out. The Danish Biotech Salary Survey... Read more